全文获取类型
收费全文 | 9232篇 |
免费 | 465篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 109篇 |
儿科学 | 770篇 |
妇产科学 | 371篇 |
基础医学 | 943篇 |
口腔科学 | 150篇 |
临床医学 | 463篇 |
内科学 | 1656篇 |
皮肤病学 | 178篇 |
神经病学 | 298篇 |
特种医学 | 290篇 |
外科学 | 1819篇 |
综合类 | 517篇 |
一般理论 | 2篇 |
预防医学 | 351篇 |
眼科学 | 541篇 |
药学 | 464篇 |
中国医学 | 21篇 |
肿瘤学 | 785篇 |
出版年
2023年 | 53篇 |
2022年 | 95篇 |
2021年 | 273篇 |
2020年 | 135篇 |
2019年 | 190篇 |
2018年 | 274篇 |
2017年 | 191篇 |
2016年 | 240篇 |
2015年 | 236篇 |
2014年 | 316篇 |
2013年 | 374篇 |
2012年 | 537篇 |
2011年 | 548篇 |
2010年 | 393篇 |
2009年 | 300篇 |
2008年 | 470篇 |
2007年 | 517篇 |
2006年 | 495篇 |
2005年 | 397篇 |
2004年 | 340篇 |
2003年 | 307篇 |
2002年 | 267篇 |
2001年 | 234篇 |
2000年 | 236篇 |
1999年 | 221篇 |
1998年 | 127篇 |
1997年 | 102篇 |
1996年 | 98篇 |
1995年 | 72篇 |
1994年 | 62篇 |
1993年 | 43篇 |
1992年 | 102篇 |
1991年 | 100篇 |
1990年 | 78篇 |
1989年 | 76篇 |
1988年 | 86篇 |
1987年 | 83篇 |
1986年 | 90篇 |
1985年 | 111篇 |
1984年 | 66篇 |
1983年 | 60篇 |
1982年 | 46篇 |
1981年 | 41篇 |
1979年 | 80篇 |
1978年 | 47篇 |
1977年 | 51篇 |
1976年 | 41篇 |
1974年 | 42篇 |
1973年 | 48篇 |
1972年 | 46篇 |
排序方式: 共有9728条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
Vein pretreatment with magnesium sulfate to prevent pain on injection of propofol is not justified 总被引:2,自引:0,他引:2
Anil Agarwal Sanjay Dhiraj Mehdi Raza Ravinder Pandey Chandra Kant Pandey Prabhat K. Singh Uttam Singh Devendra Gupta 《Journal canadien d'anesthésie》2004,51(2):130-133
PURPOSE: Propofol produces anesthesia with rapid recovery. However, it causes pain or discomfort on injection. A number of techniques have been tried for minimizing propofol-induced pain with variable results. We have compared the efficacy of magnesium and lidocaine for the prevention of propofol induced pain. METHODS: Three hundred ASA I and II adults undergoing elective surgery were randomly assigned into three groups of 100 each. Group I received magnesium sulfate 1 g, Group II received lidocaine 2% (40 mg) and Group III received normal saline, all in a volume of 2 mL and accompanied by venous occlusion for one minute. Induction with propofol 2.5 mg.kg(-1) was accomplished following the release of venous occlusion. Pain was assessed on a four-point scale: 0 = no pain, 1 = mild pain, 2 = moderate pain, and 3 = severe pain at the time of pretreatment and propofol injection. Results were analyzed by 'Z' test. A P value of < 0.05 was considered as significant. RESULTS: Pain during i.v. pretreatment with magnesium was 31% as compared to 2% for both the lidocaine and control groups (P < 0.05). Seventy-six percent of patients in the control group had pain during i.v. propofol as compared to 32% and 42% in the magnesium and the lidocaine groups respectively (P < 0.05). Lidocaine and magnesium pretreatment were equally effective in attenuating pain during the propofol injection (P > 0.05). CONCLUSIONS: Intravenous magnesium and lidocaine pretreatment are equally effective in attenuating propofol-induced pain. However, magnesium pretreatment itself causes pain. Therefore, there is no justification in the use of magnesium pretreatment for attenuating pain associated with i.v. propofol. 相似文献
996.
997.
998.
999.
Diagnosis of 6 Mercaptopurine Hepatotoxicity Post Liver Transplantation Utilizing Metabolite Assays 总被引:1,自引:0,他引:1
Nickolas Kontorinis Kaushik Agarwal Gabriel Gondolesi M. Isabel Fiel Marian O'Rourke Thomas D. Schiano 《American journal of transplantation》2004,4(9):1539-1542
Azathioprine and 6-mercaptopurine (6 MP) are commonly used as immunosuppression postsolid organ transplantation. Recently, a better understanding of the metabolism of these drugs has developed. 6 Mercaptopurine is metabolized by thiopurine methyl transferase (TPMT) which is under the control of a common genetic polymorphism. Genetic testing and measurement of levels of 6 MP metabolites allow identification of patients at risk of toxicity. We report two cases of cholestatic hepatocellular injury associated with 6 MP toxicity occurring after orthotopic liver transplantation. Cholestasis developed after the introduction of 6 MP. Patients underwent extensive investigation and 6 MP toxicity was considered only after all other causes had been excluded. Thiopurine methyl transferase alleles identified on genetic testing were normal as were the 6 thioguanine levels. However, 6-methyl mercaptopurine levels were significantly elevated into the toxic range. Cholestasis resolved within a few weeks of drug withdrawal. 6 Mercaptopurine hepatotoxicity can present with a variety of clinical, biochemical and histological manifestations post OLT and should be considered as a cause of liver enzyme elevation. Monitoring of 6 MP metabolite levels in addition to TPMT allele testing is useful to prevent 6 MP toxicity and to help guide therapy. 相似文献
1000.
BC SHARMA RP SINGH YK CHAWLA KL NARASIMHAN KLN RAO SK MITRA JB DILAWARI 《Journal of gastroenterology and hepatology》1997,12(8):582-584
Shunt surgery is considered to be the treatment of choice in patients with non-cirrhotic portal hypertension. There is little data on the effect of side-to-side lieno-renal (SSLR) shunt on oesophageal variceal size, splenic size and splenic pulp pressure (SPP) in patients with non-cirrhotic portal hypertension. We evaluated pre- and postoperatively endoscopic grading of varices, splenic size and SPP for predicting shunt patency in 86 patients with non-cirrhotic portal hypertension: 56 with extrahepatic portal venous obstruction (EHPVO) and 30 with non-cirrhotic portal fibrosis (NCPF). The EHPVO patients with patent shunts (n= 47) showed significant reduction in SPP (pre-operative 43.56±7.9 vs postoperative 29.96±7.7 cm of saline), splenic size (6.5±2.8 vs 4.00±2.6 cm below costal margin) and varices grades (2.96±0.5 vs 0.92±0.8). Patients with blocked shunt (n= 9) did not show significant reduction in SPP and varices grades. However, there was reduction in spleen size (8.6±3.0 vs 6.3±4.3). In the NCPF group, 28 had patent shunts and showed significant reduction in SPP (46.3±13.5 vs 33.8±7.6 cm of saline), splenic size (9.1±3.3 vs 6.8±4.6 cm below costal margin) and varices grades (2.8±0.7 vs 1.05±0.96). As only two patients with NCPF had blocked shunts, no statistical comparison between patients with patent and patients with blocked shunts could be done. In conclusion, following SSLR, there is a significant reduction in SPP and varices grades in patients with patent shunts. Endoscopic grading of varices can be used to predict shunt patency. However, spleen size is not a good criteria for predicting shunt patency. 相似文献